Assessing disease progression using a composite endpoint
From MaRDI portal
Recommendations
- Data-driven desirability function to measure patients’ disease progression in a longitudinal study
- Efficient analysis of time-to-event endpoints when the event involves a continuous variable crossing a threshold
- Consistency-adjusted alpha allocation methods for a time-to-event analysis of composite endpoints
- Efficient estimation of the distribution of time to composite endpoint when some endpoints are only partially observed
- An expected power approach for the assessment of composite endpoints and their components
Cites work
Cited in
(3)
This page was built for publication: Assessing disease progression using a composite endpoint
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5425025)